The Current Ratio as of December 2025 (TTM) for Xbrane Biopharma AB (publ) (XBRANE.ST) is 3.47

According to Xbrane Biopharma AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 3.47. This represents a change of 85.06% compared to the average of 1.88 of the last 4 quarters.

Xbrane Biopharma AB (publ) (XBRANE.ST) Historical Current Ratio (quarterly & annually)

How has XBRANE.ST Current Ratio performed in the past?

The mean historical Current Ratio of Xbrane Biopharma AB (publ) over the last ten years is 2.13. The current 3.47 Current Ratio has changed 16.20% with respect to the historical average. Over the past ten years (40 quarters), XBRANE.ST's Current Ratio was at its highest in in the December 2016 quarter at 7.40. The Current Ratio was at its lowest in in the December 2015 quarter at 0.32.

Xbrane Biopharma AB (publ) (XBRANE.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Xbrane Biopharma AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xbrane Biopharma AB (publ) (XBRANE.ST) Average Current Ratio

How has XBRANE.ST Current Ratio performed in the past?

The current Current Ratio of Xbrane Biopharma AB (publ) (XBRANE.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Xbrane Biopharma AB (publ) (XBRANE.ST) Current Ratio vs. Peers

How is XBRANE.ST’s Current Ratio compared to its peers?

Xbrane Biopharma AB (publ)’s Current Ratio is greater than Scandinavian ChemoTech AB (publ) (1.17), greater than Biovica International AB (publ) (0.86), greater than Nanologica AB (publ) (2.50), greater than Alzinova AB (publ) (0.20), greater than Active Biotech AB (publ) (1.17), less than Biosergen AB (7.09), greater than SciBase Holding AB (publ) (2.49), less than Neola Medical AB (publ) (5.61), less than NextCell Pharma AB (10.02), less than AcuCort AB (8.28),

Build a custom stock screener for Xbrane Biopharma AB (publ) (XBRANE.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xbrane Biopharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xbrane Biopharma AB (publ) (XBRANE.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xbrane Biopharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.